Raymond Prudo Chlebosz Akari Therapeutics PLC (AKTX) insider trading activity
Raymond Prudo Chlebosz is of Akari Therapeutics Plc. Currently has a direct ownership of 4.08 Billion shares of AKTX, which is worth approximately $4.08 Billion. The most recent transaction as insider was on Dec 02, 2024, when has been sold 419,286,000 shares (Ordinary shares, par value $0.0001 per share) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
4.08B
11.46%
3M change
n/a
12M change
Total Value Held
$4.08 Billion
Raymond Prudo-Chlebosz Transaction History
RP
Raymond Prudo Chlebosz
Boston, MA